Study name |
Study period (year to year) |
Setting/Country |
Description of participants |
Intervention(s) and comparator(s) |
Duration of follow‐up |
Age |
IPSS |
Prostate volume |
Gilling 2018 |
October 2015‐December 2016 |
Multicenter (17 centres)/multicountry (Australia, New Zealand, UK, USA) |
LUTS due to BPH in men 45‐80 years of age with a prostate size between 30 and 80 mL (measured with transrectal ultrasound), IPSS ≥ 12, Qmax < 15mL/s |
Aquablation |
12 months |
66.0 ± 7.3 |
22.9 ± 6.0 |
54.1 ± 16.2 |
TURP (monopolar 36 (55.4%), bipolar 29 (44.6%)) |
65.8 ± 7.2 |
22.2 ± 6.1 |
51.8 ± 13.8 |
BPH: benign prostatic hyperplasia; IPSS: International Prostate Symptom Score; LUTS: low urinary tract symptoms; Qmax: maximum flow rate; TURP: transurethral resection of prostate |